Pinchas Tsukerman
  • Nectin Therapeutics
  • Immunology


M.S. in Immunology, Lautneberg Center, Hebrew University, Jerusalem, Israel.

Current position

Ph.D. student at Professor Ofer Mandelboim lab Lautneberg Center, Hebrew University, Jerusalem, Israel.


  1. Tsukerman, P., Enk, J. and Mandelboim, O. (2013). Metastamir-mediated immune evasion: miR-10b downregulates the stress-induced molecule MICB, hence avoid recognition by NKG2D receptor. Oncoimmunology 2(1): e22245.
  2. Tsukerman, P., Stern-Ginossar, N., Gur, C., Glasner, A., Nachmani, D., Bauman, Y., Yamin, R., Vitenshtein, A., Stanietsky, N., Bar-Mag, T., Lankry, D. and Mandelboim, O. (2012). MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells. Cancer Res 72(21): 5463-5472.
  3. Glasner, A., Zurunic, A., Meningher, T., Lenac Rovis, T., Tsukerman, P., Bar-On, Y., Yamin, R., Meyers, A. F., Mandeboim, M., Jonjic, S. and Mandelboim, O. (2012). Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS ONE 7(5): e36837.
  4. Manaster, I., Goldman-Wohl, D., Greenfield, C., Nachmani, D., Tsukerman, P., Hamani, Y., Yagel, S. and Mandelboim, O. (2012). MiRNA-mediated control of HLA-G expression and function. PLoS ONE 7(3): e33395.
  5. Glasner, A., Ghadially, H., Gur, C., Stanietsky, N., Tsukerman, P., Enk, J. and Mandelboim, O. (2012). Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1. J Immunol 188(6): 2509-2515.
  6. Bauman, Y., Nachmani, D., Vitenshtein, A., Tsukerman, P., Drayman, N., Stern-Ginossar, N., Lankry, D., Gruda, R. and Mandelboim, O. (2011). An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 9(2): 93-102.
  7. Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., Levine, Z., Beiman, M., Dassa, L., Achdout, H., Stern-Ginossar, N., Tsukerman, P., Jonjic, S. and Mandelboim, O. (2009). The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc Natl Acad Sci U S A 106(42): 17858-17863.